Transcranial Pulse Stimulation (TPS) plays a major role at professional congresses
Noninvasive brain stimulation techniques are becoming increasingly relevant for therapy and rehabilitation
Neurostimulation methods have been an intensive field of research and development for decades. Today they are considered central topics at international neurological congresses and conferences and generate great interest. Expert:ins attribute great importance in the modern treatment of neurophysiological diseases to these new medical therapeutic options, also known as brain stimulation methods. Of particular interest is the neurostimulation therapy Transcranial Pulse Stimulation (TPS). This method can be performed on an outpatient basis and noninvasively, which makes it particularly attractive to patients.
Neurostimulation: Research and development unlocks new medical possibilities
Pharmaceutical treatments, based on the development and chemical synthesis of drugs in the 19th and 20th centuries, are at the forefront of our medicine. Now, in the 21st century, medicine is fundamentally expanding to include physical aspects, especially in therapy.
Unlike most drugs, which are based on chemical substances to target biochemical processes in the body, neurostimulation methods are based on physics. They use physical phenomena such as electricity, magnetism or sound waves to directly affect the nervous system and control neuronal activities.
The new neurostimulation methods use electrical, magnetic or mechanical-energetic stimuli to influence activity in the Human Brain. They are used not only to study brain function, but also to treat various diseases. These include Alzheimer’s disease, dementia, depression, Parkinson’s disease, epilepsy and chronic pain.
Known forms of neurostimulation include transcranial magnetic stimulation (TMS), deep brain stimulation (DBS) and vagus nerve stimulation (VNS). However, Transcranial Pulse Stimulation (TPS) is already particularly widespread in clinical practice. It is efficient and only occasionally causes minor side effects.
TPS at international congresses: Numerous scientific papers presented
At the “9th European Academy of Neurology Congress” or EAN Congress for short, held in Budapest, Hungary, in July 2023, and at the AAIC Conference (Alzheimer’s Association International Conference), the world’s largest professional forum for scientists:ing research into new methods of prevention, diagnosis, and treatment in the field of dementia diseases, Transcranial Pulse Stimulation (TPS) was also represented in Amsterdam, the Netherlands, in July 2023, with poster presentations including the following:
“1 year follow-up after Transcranial Pulse Stimulation in Alzheimer’s patients”.
Authors: Lars Wojtecki et al.
“TPS with the system Neurolith as a method in the treatment of the central nervous system of patients with Alzheimer’s disease”
Authors Marc Ziegenbein et al.
“Longterm results of Alzheimer’s Dementia treated with Transcranial Pulse Stimulation”
Author: Henning Lohse-Busch
“Transcranial Pulse Stimulation (TPS) in Alzheimer’s: Long-term retrospective group data and individual patient histories”
Authors Lars Wojtecki et al.
Transcranial Pulse Stimulation (TPS) at the “3rd Joint Congress of the INS European Chapters” in Hamburg
Transcranial Pulse Stimulation (TPS) will also be represented at the “3rd Joint Congress of the INS European Chapters,” which will be held from August 31 to September 2, 2023. This congress brings together the “who’s who” of the international research community in brain stimulation methods. It provides neuromodulation specialists, basic researchers, biomedical engineers, and other industry members with the opportunity to comprehensively learn, share, and network about the latest findings and opportunities in neurostimulation.
International research on shockwave therapy Transcranial Pulse Stimulation (TPS) has meanwhile expanded its focus to include other indications such as depression, ADHD, fatigue and autism, in addition to Alzheimer’s and Parkinson’s basic research. At the congress in Hamburg, research results will be presented that show how TPS therapy can improve treatment options for patients. As an outpatient treatment option, it can be used in addition to drug therapy.
Through their presence at these and future conferences and congresses, the scientists involved in TPS research are helping to raise awareness of this method among professionals. The goal is to give more and more people affected by neurodegenerative and neurophysiological diseases access to this already available treatment option. Together with other brain stimulation methods, TPS could become an integral part of the multimodal therapeutic spectrum in neurology and psychiatry in the future.
Further information on the “3rd Joint Congress of the INS European Chapters” in Hamburg:
